Close Menu

NEW YORK – Agios Pharmaceuticals said on Monday that it has partnered with PerkinElmer Genomics on a genetic testing program for patients with suspected hereditary anemias.

Testing will be performed using a next-generation sequencing-based panel comprising more than 50 genes and disorders known to cause hereditary anemias, such as pyruvate kinase deficiency.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.